The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trabectedin (T) as second line treatment option for patients with epithelioid malignant pleural mesothelioma (MPM) in progression following pemetrexed/platin-derivates chemotherapy: ATREUS trial.
 
Diego Luigi Cortinovis
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Roche
 
Lital Hannah Hollander
No Relationships to Disclose
 
Luciano Carlucci
No Relationships to Disclose
 
Federica Grosso
Travel, Accommodations, Expenses - Boehringer Ingelheim; PharmaMar
 
Giovanni Luca Ceresoli
No Relationships to Disclose
 
Ilaria Pacchetti
No Relationships to Disclose
 
Paolo Andrea Zucali
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Sanofi
 
Maurizio D'Incalci
Consulting or Advisory Role - PharmaMar
 
Marcello Tiseo
Consulting or Advisory Role - Lilly; MSD; Novartis; Pierre Fabre
 
Lorenzo Legramandi
No Relationships to Disclose
 
Stefania Canova
No Relationships to Disclose
 
Francesca Ugo
No Relationships to Disclose
 
Maria Ida Abbate
No Relationships to Disclose
 
Giacomo Taverna
No Relationships to Disclose
 
Viola Cogliati
No Relationships to Disclose
 
Paolo Bidoli
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly